Aktiviere Job-Benachrichtigungen per E-Mail!
A leading biopharmaceutical company in Switzerland is seeking a Medical Affairs Manager to manage relationships with key opinion leaders and provide scientific support to marketing efforts. Candidates should have a Master’s degree or PhD, minimum 3 years of experience in the pharmaceutical industry, and proficiency in German, French, and English. This is a field-based role with approximately 20% office presence in Villars-sur-Glâne.
Location:
Field-based, CH
Division: Medical Affairs
Job Type: Permanent role
Our Swiss affiliate in Fribourg is seeking a Medical Affairs Manager to join one of its Brand Teams, focusing on key products within our Central Nervous System (CNS) portfolio. As part of a dedicated team of four and reporting to the Medical Affairs Team Lead, your mission will be to build and nurture strong relationships with KOLs, specialists and GPs.
Your main responsibilities are as follows:
Please note that this a field-based position requiring approximatively 20% presence at our office in Villars-sur-Glâne.
To carry out this mission, we are looking for a person with the following profile:
You are recognized for being both a team player with excellent collaboration skills and a self-directed professional who takes initiatives with an entrepreneurial mindset. Your outstanding communication skills enable you to interact effectively with diverse stakeholders, foster long-term trust with HCPs, and deliver clear and engaging trainings and presentations. Leveraging your scientific background and analytical mindset, you demonstrate a strong ability to synthesize and interpret scientific data.
Shape the future of healthcare – apply now to join OM Pharma as a Medical Affairs Manager.
OM Pharma is a global Geneva-based biopharmaceutical company. It is a leader in the prevention of recurrent respiratory and urinary tract infections and is also active in the treatment of vascular diseases. It operates worldwide through a strong network of international partners and invests its profits in R&D to develop microbial derived immunotherapeutic products to treat acute and chronic immunological disorders resulting from inflammation and infections. The company strives to improve the quality of life of patients around the world by providing access to better treatment of immunological imbalances.